Annual Interest Expense
$8.67 M
+$2.30 M+36.12%
31 December 2023
Summary:
Poseida Therapeutics annual interest expense is currently $8.67 million, with the most recent change of +$2.30 million (+36.12%) on 31 December 2023. During the last 3 years, it has risen by +$5.17 million (+147.32%). PSTX annual interest expense is now at all-time high.PSTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$2.29 M
+$36.00 K+1.59%
30 September 2024
Summary:
Poseida Therapeutics quarterly interest expense is currently $2.29 million, with the most recent change of +$36.00 thousand (+1.59%) on 30 September 2024. Over the past year, it has increased by +$59.00 thousand (+2.64%). PSTX quarterly interest expense is now at all-time high.PSTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$9.07 M
+$59.00 K+0.65%
30 September 2024
Summary:
Poseida Therapeutics TTM interest expense is currently $9.07 million, with the most recent change of +$59.00 thousand (+0.65%) on 30 September 2024. Over the past year, it has increased by +$694.00 thousand (+8.28%). PSTX TTM interest expense is now at all-time high.PSTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.1% | +2.6% | +8.3% |
| 3 y3 years | +147.3% | +174.2% | +169.3% |
| 5 y5 years | +382.8% | +145.4% | +244.6% |
PSTX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +158.2% | at high | +174.2% | at high | +170.2% |
| 5 y | 5 years | at high | +382.8% | at high | +174.2% | at high | +244.6% |
| alltime | all time | at high | +1453.9% | at high | +188.7% | at high | +1041.4% |
Poseida Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.29 M(+1.6%) | $9.07 M(+0.7%) |
| June 2024 | - | $2.26 M(+0.3%) | $9.02 M(+1.3%) |
| Mar 2024 | - | $2.25 M(-0.6%) | $8.90 M(+2.6%) |
| Dec 2023 | $8.67 M(+36.1%) | $2.27 M(+1.4%) | $8.67 M(+3.5%) |
| Sept 2023 | - | $2.24 M(+4.4%) | $8.38 M(+5.8%) |
| June 2023 | - | $2.14 M(+5.6%) | $7.92 M(+8.2%) |
| Mar 2023 | - | $2.03 M(+2.7%) | $7.32 M(+14.9%) |
| Dec 2022 | $6.37 M(+89.7%) | $1.98 M(+11.3%) | $6.37 M(+21.7%) |
| Sept 2022 | - | $1.77 M(+15.0%) | $5.24 M(+21.8%) |
| June 2022 | - | $1.54 M(+43.3%) | $4.30 M(+19.5%) |
| Mar 2022 | - | $1.08 M(+28.2%) | $3.60 M(+7.1%) |
| Dec 2021 | $3.36 M | $840.00 K(+0.4%) | $3.36 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $837.00 K(-0.7%) | $3.37 M(-0.3%) |
| June 2021 | - | $843.00 K(+0.6%) | $3.38 M(-1.4%) |
| Mar 2021 | - | $838.00 K(-1.6%) | $3.43 M(-2.2%) |
| Dec 2020 | $3.51 M(-1.3%) | $852.00 K(+0.5%) | $3.51 M(-1.9%) |
| Sept 2020 | - | $848.00 K(-4.9%) | $3.57 M(-2.4%) |
| June 2020 | - | $892.00 K(-2.4%) | $3.66 M(-0.3%) |
| Mar 2020 | - | $914.00 K(-0.7%) | $3.67 M(+3.3%) |
| Dec 2019 | $3.55 M(+97.8%) | $920.00 K(-1.6%) | $3.55 M(+34.9%) |
| Sept 2019 | - | $935.00 K(+3.5%) | $2.63 M(+55.1%) |
| June 2019 | - | $903.00 K(+13.6%) | $1.70 M(+113.6%) |
| Mar 2019 | - | $795.00 K | $795.00 K |
| Dec 2018 | $1.80 M(+221.9%) | - | - |
| Dec 2017 | $558.00 K | - | - |
FAQ
- What is Poseida Therapeutics annual interest expense?
- What is the all time high annual interest expense for Poseida Therapeutics?
- What is Poseida Therapeutics annual interest expense year-on-year change?
- What is Poseida Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly interest expense year-on-year change?
- What is Poseida Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Poseida Therapeutics?
- What is Poseida Therapeutics TTM interest expense year-on-year change?
What is Poseida Therapeutics annual interest expense?
The current annual interest expense of PSTX is $8.67 M
What is the all time high annual interest expense for Poseida Therapeutics?
Poseida Therapeutics all-time high annual interest expense is $8.67 M
What is Poseida Therapeutics annual interest expense year-on-year change?
Over the past year, PSTX annual interest expense has changed by +$2.30 M (+36.12%)
What is Poseida Therapeutics quarterly interest expense?
The current quarterly interest expense of PSTX is $2.29 M
What is the all time high quarterly interest expense for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly interest expense is $2.29 M
What is Poseida Therapeutics quarterly interest expense year-on-year change?
Over the past year, PSTX quarterly interest expense has changed by +$59.00 K (+2.64%)
What is Poseida Therapeutics TTM interest expense?
The current TTM interest expense of PSTX is $9.07 M
What is the all time high TTM interest expense for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM interest expense is $9.07 M
What is Poseida Therapeutics TTM interest expense year-on-year change?
Over the past year, PSTX TTM interest expense has changed by +$694.00 K (+8.28%)